Adaptimmune, a biotech company focused on using T-cell therapy to treat cancer and infectious disease, has secured $104 million in Series A financing. New Enterprise Associates (NEA) led the round, and other new investors included OrbiMed Advisors LLC, Wellington Management Company, LLP, Fidelity Biosciences, Foresite Capital Management, Ridgeback Capital Management, Novo A/S, QVT, Rock Springs Capital, venBio Select and Merlin Nexus. The University of Oxford was among the existing investors which also participated. “We are delighted to secure this strong financial support from some of the most prestigious and highly regarded biotechnology investment groups in the US, led by NEA,” said Adaptimmune CEO James Noble. “Their commitment, and the perspective and experience of our new board members, will be invaluable as we build the company up and accelerate the development of our own pipeline of clinical programs.”
Sao Paulo-based financial services company Nubank has raised $14.3 million in a Series A round led by Sequoia Capital, according to the New York Times. Kaszek Ventures and Silicon Valley Bank also participated in the round, which was Sequoia’s first investment in a Brazilian company. Nubank also launched a Mastercard platinum credit card which can be managed through an Android or iOS app, allowing users to avoid fees and high interest rates.
Context Relevant, a big data analytics company that works in the finance sector, has completed a $13.5 million Series B-1 financing round, with participation from Goldman Sachs, Bank of America Merrill Lynch, Formation 8, New York Life, and Bloomberg Beta. The company previously raised a Series B round worth $21 million earlier in the year. “We have the right software, the right people and the right partners to make a difference in protecting and improving the global financial system, which is the number one job of our team,” said Stephen Purpura, CEO of Context Relevant. “Our technology is not just for data scientists, it is used throughout our clients’ workforce. The platform represents a disruptive quantum leap over existing analytics solutions used in financial services.”
Taulia, a supplier-financing company, has raised $13 million in additional Series D financing, bringing the round’s total to $40 million. The company received additional interest in investment after its $27 million initial round in July. The additional funds came from BBVA Ventures and EDBI, the corporate investment arm of Singapore’s Economic Development Board. “We’re very pleased to see continued and growing interest in our solutions across the globe,” said Taulia CEO Bertram Meyer. “It’s exciting to see our significant market traction recognized by these leading international investors, BBVA and EDBI.”